Heat Biologics, Inc. (NASDAQ:HTBX) CEO Jeff Wolf tells Proactive the North Carolina-based biopharma is continuing to advance its coronavirus vaccine in collaboration with researchers at the University of Miami.
Wolf says Heat’s vaccine is being designed to clear virus infected cells by promoting long-term cellular immunity, which may help prevent the spread of re-infection.
